1,164
Views
13
CrossRef citations to date
0
Altmetric
Research Papers

Dynamics of the serologic response in vaccinated and unvaccinated mumps cases during an epidemic

, , , , , & show all
Pages 1754-1761 | Received 06 Feb 2015, Accepted 09 Apr 2015, Published online: 06 Jul 2015

References

  • Mumps virus vaccines. Weekly epidemiological record (WHO); 2007; 7:51-60.
  • Karagiannis I, van Lier A, van Binnendijk RS, Ruijs H, Fanoy E, Conyn-Van Spaendonck MA, de Melker H, Hahné S. Mumps in a community with low vaccination coverage in the Netherlands. Eurosurveillance (Weekly) 2008; 13; PMID:18761946.
  • Plotkin SA, Rubin SA. Mumps vaccines (Chapter 20). Saunders (Elsevier Inc.); 2008.
  • Dowdle WR, Orenstein WA. Quest for life-long protection by vaccination. Proc Natl Acad Sci U S A 1994; 91:2464-8; PMID:8146140; http://dx.doi.org/10.1073/pnas.91.7.2464.
  • Vandermeulen C, Roelants M, Vermoere M, Roseeuw K, Goubau P, Hoppenbrouwers K. Outbreak of mumps in a vaccinated child population: a question of vaccine failure? Vaccine 2004; 22:2713-6; PMID:15246601; http://dx.doi.org/10.1016/j.vaccine.2004.02.001.
  • Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, Brown D, Ramsay ME. Vaccine effectiveness estimates, 2004–2005 mumps outbreak, England. Emerg Infect Dis 2007; 13:12-7; PMID:17370510.
  • Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, Hunt K, Finley CG, Leschinsky DP, O'Keefe AL, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008; 358:1580-9; PMID:18403766; http://dx.doi.org/10.1056/NEJMoa0706589.
  • Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin Infect Dis 2007; 45:459-66; PMID:17638194; http://dx.doi.org/10.1086/520028.
  • Schwarz NG, Bernard H, Melnic A, Bucov V, Caterinciuc N, an der Heiden M, Andrews N, Pebody R, Aidyralieva C, Hahné S. Mumps outbreak in the Republic of Moldova, 2007–2008. Pediatr Infect Dis J 2010; 29:703-6; PMID:20308934; http://dx.doi.org/10.1097/INF.0b013e3181d743df.
  • Hassan J, Dean J, Moss E, Carr MJ, Hall WW, Connell J. Seroepidemiology of the recent mumps virus outbreaks in Ireland. J Clin Virol 2012; 53:320-4; PMID:22269391; http://dx.doi.org/10.1016/j.jcv.2011.12.022.
  • Brockhoff HJ, Mollema L, Sonder GJ, Postema CA, van Binnendijk RS, Kohl RH, de Melker HE, Hahné SJ. Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004. Vaccine 2010; 28:2932-6; PMID:20188683; http://dx.doi.org/10.1016/j.vaccine.2010.02.020.
  • Karagiannis I, van Lier A, van Binnendijk R, Ruijs H, Fanoy E, Conyn-Van Spaendonck MA, de Melker H, Hahné S. Mumps in a community with low vaccination coverage in the Netherlands. Euro Surveill 2008; 13; PMID:18761946.
  • Kaaijk P, van der Zeijst B, Boog M, Hoitink C. Increased mumps incidence in the Netherlands: review on the possible role of vaccine strain and genotype. Euro Surveill 2008; 13; PMID:18761918.
  • Braeye T, Linina I, De Roy R, Hutse V, Wauters M, Cox P, Mak R. Mumps increase in Flanders, Belgium, 2012–2013: results from temporary mandatory notification and a cohort study among university students. Vaccine 2014; 32:4393-8; PMID:24973734; http://dx.doi.org/10.1016/j.vaccine.2014.06.069.
  • Greenland K, Whelan J, Fanoy E, Borgert M, Hulshof K, Yap KB, Swaan C, Donker T, van Binnendijk R, de Melker H, et al. Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010. Vaccine 2012; 30:4676-80; PMID:22579874; http://dx.doi.org/10.1016/j.vaccine.2012.04.083.
  • Kontio M, Jokinen S, Paunio M, Peltola H, Davidkin I. Waning antibody levels and avidity: implications for MMR vaccine-induced protection. J Infect Dis 2012; 206:1542-8; PMID:22966129; http://dx.doi.org/10.1093/infdis/jis568.
  • Rubin SA, Qi L, Audet SA, Sullivan B, Carbone KM, Bellini WJ, Rota PA, Sirota L, Beeler J. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis 2008; 198:508-15; PMID:18558869; http://dx.doi.org/10.1086/590115.
  • Andrews N, Pebody RG, Berbers G, Blondeau C, Crovari P, Davidkin I, Farrington P, Fievet-Groyne F, Gabutti G, Gerike E, et al. The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella. Epidemiol Infect 2000; 125:127-41; PMID:11057968; http://dx.doi.org/10.1017/S0950268899004173.
  • Smits G, Mollema L, Hahne S, de Melker H, Tcherniaeva I, Waaijenborg S, van Binnendijk R, van der Klis F, Berbers G. Seroprevalence of mumps in The Netherlands: dynamics over a decade with high vaccination coverage and recent outbreaks. PLoS One 2013; 8:e58234; PMID:23520497; http://dx.doi.org/10.1371/journal.pone.0058234.
  • Gouma S, Schurink-van't Klooster TM, de Melker HE, Kerkhof J, Smits GP, Hahné SJM, et al. Mumps serum antibody levels before and after an outbreak to assess infection and immunity in vaccinated students. Open Forum Infect Dis 2014; 1(3):ofu101; PMID:25734169; http://dx.doi.org/10.1093/ofid/ofu101; Accepted for publication.
  • van Lier E, Oomen PJ, Mulder M, Conyn-van Spaendonck MA, Drijfhout IH, de Hoogh PAAM, et al. RIVM Rapport 150202001/2013 Immunisation coverage National Immunisation Programme in the Netherlands; Year of report 2013. 2013 [in Dutch; summary in English].
  • Anderson RM, May RM. Vaccination and herd immunity to infectious diseases. Nature 1985; 318:323-9; PMID:3906406; http://dx.doi.org/10.1038/318323a0.
  • Wallinga J, Teunis P, Kretzschmar M. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am J Epidemiol 2006; 164:936-44; PMID:16968863; http://dx.doi.org/10.1093/aje/kwj317.
  • Sane J, Gouma S, Koopmans M, de Melker H, Swaan C, van Binnendijk R, Hahné S. Epidemic of mumps among vaccinated persons, The Netherlands, 2009–2012. Emerg Infect Dis 2014; 20:643-8; PMID:24655811; http://dx.doi.org/10.3201/eid2004.131681.
  • Gouma S, Sane J, Gijselaar D, Cremer J, Hahne S, Koopmans M, van van Binnendijk R. Two major mumps genotype G variants dominated recent mumps outbreaks in the Netherlands (2009–2012). J Gen Virol 2014; 95:1074-82; PMID:24603524; http://dx.doi.org/10.1099/vir.0.062943-0.
  • Gut JP, Lablache C, Behr S, Kirn A. Symptomatic mumps virus reinfections. J Med Virol 1995; 45:17-23; PMID:7714488; http://dx.doi.org/10.1002/jmv.1890450104.
  • Crowley B, Afzal MA. Mumps virus reinfection–clinical findings and serological vagaries. Commun Dis Public Health 2002; 5:311-3; PMID:12564247.
  • Yoshida N, Fujino M, Miyata A, Nagai T, Kamada M, Sakiyama H, Ihara T, Kumagai T, Okafuji T, Okafuji T, et al. Mumps virus reinfection is not a rare event confirmed by reverse transcription loop-mediated isothermal amplification. J Med Virol 2008; 80:517-23; PMID:18205215; http://dx.doi.org/10.1002/jmv.21106.
  • Date AA, Kyaw MH, Rue AM, Klahn J, Obrecht L, Krohn T, Rowland J, Rubin S, Safranek TJ, Bellini WJ, et al. Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis 2008; 197:1662-8; PMID:18419346; http://dx.doi.org/10.1086/588197.
  • Latner DR, McGrew M, Williams NJ, Sowers SB, Bellini WJ, Hickman CJ. Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method. Clin Vaccine Immunol 2014; 21:286-97; PMID:24371258; http://dx.doi.org/10.1128/CVI.00621-13.
  • Gouma S, Schurink-Van't Klooster TM, de Melker HE, Kerkhof J, Smits GP, Hahne SJ, van Els CA, Boland GJ, Vossen AC, Goswami PR, et al. Mumps serum antibody levels before and after an outbreak to assess infection and immunity in vaccinated students. Open Forum Infect Dis 2014; 1:ofu101; PMID:25734169.
  • Cortese MM, Barskey AE, Tegtmeier GE, Zhang C, Ngo L, Kyaw MH, Baughman AL, Menitove JE, Hickman CJ, Bellini WJ, et al. Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity. J Infect Dis 2011; 204:1413-22; PMID:21933874; http://dx.doi.org/10.1093/infdis/jir526.
  • Smits GP, van Gageldonk PG, Schouls LM, van der Klis FR, Berbers GA. Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus. Clin Vaccine Immunol 2012; 19:396-400; PMID:22237896; http://dx.doi.org/10.1128/CVI.05537-11.
  • Vaidya SR, Brown DW, Jin L, Samuel D, Andrews N, Brown KE. Development of a focus reduction neutralization test (FRNT) for detection of mumps virus neutralizing antibodies. J Virol Methods 2010; 163:153-6; PMID:19761798; http://dx.doi.org/10.1016/j.jviromet.2009.09.006.